Foamix Pharmaceuticals' FDA Application Accepted For Review, Catalyst Laid Out Ahead [Seeking Alpha]
FOAMIX PHARMACEUTICALS LTD (FOMX)
Last foamix pharmaceuticals ltd earnings: 11/11 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.foamix.co.il
Company Research
Source: Seeking Alpha
Foamix Pharmaceuticals' FDA Application Accepted For Review, Catalyst Laid Out Ahead Summary Foamix announced that the FDA had accepted the application for review of its drug FMX103 to treat patients with papulopustular rosacea. The biotech has already received FDA approval for another drug in the pipeline known as Amzeeq to treat patients with moderate to severe acne. The global acne market is expected to be worth $5.9 billion by 2025. Foamix has another drug in the pipeline that is being developed to treat patients with acne known as FCD105. Foamix Pharmaceuticals FOMX announced that the FDA had accepted its application for review NDA Accepted for FMX103 For Treatment Of Papulopustular Rosacea The FDA had announced that it accepted the NDA for FMX103 to treat patients with papulopustular rosacea for adults. The PDUFA date set for potential approval of this topical foam treatment is set for June 2, 2020. First before diving into this, it must be known what Rosacea is. Rosacea is a co
Show less
Read more
Impact Snapshot
Event Time:
FOMX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FOMX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FOMX alerts
High impacting FOAMIX PHARMACEUTICALS LTD news events
Weekly update
A roundup of the hottest topics